Status:
UNKNOWN
The Diagnostic Value of 18F-FET PET/MRI for CNS Tumors in Children and Adolescents
Lead Sponsor:
Rigshospitalet, Denmark
Collaborating Sponsors:
Børnecancerfonden
Conditions:
Positron-Emission Tomography
Brain Neoplasms, Childhood
Eligibility:
All Genders
Phase:
NA
Brief Summary
To investigate the diagnostic value of 18F-FET PET/MRI instead of MRI alone, children and adolescents with tumor in brain or spinal cord are included and scanned primarily at our hybrid PET/MRI using ...
Detailed Description
Background. Tumors in the brain and spinal cord are among the most common causes of death and disability by cancer in children and adolescents. MRI is used for primary diagnosis as well as follow-up b...
Eligibility Criteria
Inclusion
- Suspicion of newly diagnosed CNS tumor, recurrence or radiation therapy planning
- age \<18 years at first CT/MRI suggesting CNS tumor
- written informed consent from parents (age \< 18 years) or the patient (age \>18 years)
Exclusion
- contraindications for MRI (e.g. metal implants)
- pregnancy
- known syndrome with increased sensitivity to radiation (e.g. Gorlin or Ataxia Telangiectasia
Key Trial Info
Start Date :
February 24 2015
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2020
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03402425
Start Date
February 24 2015
End Date
December 31 2020
Last Update
March 28 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Copenhagen University Hospital Rigshospitalet
Copenhagen, Copenhagen O, Denmark, DK-2100